No Data
PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Shareholders Might Be Looking For Exit
Morgan Stanley's Heavyweight Robotics Almanac: AI Moves Toward Physical Embodiment, Robots Experience 'Cambrian Explosion,' with China Showing Clear Leadership
Morgan Stanley predicts that by 2050, global robot hardware sales will surge from approximately USD 100 billion in 2025 to USD 25 trillion, with unit sales increasing from 24 million to 1.4 billion. China demonstrates a clear leading advantage, particularly in terms of policy support, control over key materials, and manufacturing capabilities. By 2050, China is expected to account for approximately 26% of global robot sales.
PROCEPT BioRobotics Initiated at Buy by UBS
UBS Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Maintains Target Price $62
UBS Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Raises Target Price to $62
Sector Update: Health Care Stocks Lower in Afternoon Trading